Seller record · Telehealth service

TrimRx

By Peptide Alliance, Editorial publisherRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 2 of 8 criteria. S3, pharmacy identification: The footer names a legal category rather than a pharmacy, and no pharmacy name appears on the homepage, treatment, FAQ, contact, about, safety, shipping, terms or privacy pages. 1 more criterion also fails; see the table below.

At a glance

TrimRxTelehealth service

6/8criteria passed

Price: GLP-1 $199 first month, then $299
Sells: compounded semaglutide programs, compounded tirzepatide programs, and 1 more
FDA letters: None on file

Visit TrimRx See all eight dispositions

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

A California telehealth platform connecting buyers with third-party clinician networks for GLP-1 treatment. It states that it is neither a medical practice nor a pharmacy, and it names no filling pharmacy anywhere on the site.

Operating entity Metafit Pharma Solutions, Inc.

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	TrimRx's terms and conditions
S2	Prescription gating	PASS	TrimRx's name page on its sign-up site
S3	Pharmacy identification	FAIL	TrimRx's website
S4	Compounding disclosure	PASS	TrimRx's website
S5	Analytical documentation	FAIL	TrimRx's safety information page
S6	Business address	PASS	TrimRx's contact page
S7	Price disclosure	PASS	TrimRx's terms and conditions
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSThe terms state that an affiliated healthcare provider decides medical appropriateness and issues any prescription; no individual clinician is named.Source: TrimRx's terms and conditions.

S2PASSThe third intake screen stops the order, demanding identity data before any product selection or payment.Source: TrimRx's name page on its sign-up site.

S3FAILThe footer names a legal category rather than a pharmacy, and no pharmacy name appears on the homepage, treatment, FAQ, contact, about, safety, shipping, terms or privacy pages.Source: TrimRx's website.

S4PASSThe footer carries the words compounded and not FDA-approved in visible text, and the safety information page repeats the disclosure.Source: TrimRx's website.

S5FAILNo certificate of analysis, chromatogram or lot document is linked anywhere on the site, and the safety page instead states that quality varies between compounding pharmacies.Source: TrimRx's safety information page.

S6PASSThe contact page prints a street address with a suite number under a heading reading Our Offices, repeated in the terms mailing block.Source: TrimRx's contact page.

S7PASSThe terms price the initial GLP-1 package at 199 dollars for the first month and 299 dollars thereafter, while the homepage tile prints starting at 179 dollars with no term attached.Source: TrimRx's terms and conditions.

S8PASSNo FDA warning letter names the entity, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide programs, compounded tirzepatide programs, prescriptions for branded Ozempic and Zepbound.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide

Visit TrimRx

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.